Inflammatory prognostic biomarkers in advanced non-small cell lung cancer

Pulmonology. 2019 May-Jun;25(3):181-183. doi: 10.1016/j.pulmoe.2019.02.007. Epub 2019 Mar 29.

Authors

D Machado¹, C Marques², M Dias³, S Campainha³, A Barroso³

Affiliations

¹ Pulmonology Department, Gaia/Espinho Hospital Center, Vila Nova de Gaia, Portugal. Electronic address: [email protected].
² Pulmonology Department, Gaia/Espinho Hospital Center, Vila Nova de Gaia, Portugal.
³ Thoracic Tumors Multidisciplinary Unit, Pulmonology Department, Gaia/Espinho Hospital Center, Vila Nova de Gaia, Portugal.

PMID: 30935945
DOI: 10.1016/j.pulmoe.2019.02.007

No abstract available

Publication types

Letter

MeSH terms

Aged
C-Reactive Protein / analysis*
Carcinoma, Non-Small-Cell Lung / blood
Carcinoma, Non-Small-Cell Lung / diagnosis*
Carcinoma, Non-Small-Cell Lung / mortality
Female
Humans
Inflammation / blood
Inflammation / diagnosis
Kaplan-Meier Estimate
Leukocyte Count
Lung Neoplasms / blood
Lung Neoplasms / diagnosis*
Lung Neoplasms / mortality
Lymphocyte Count
Male
Neutrophils
Prognosis
Retrospective Studies
Survival Analysis

Substances

C-Reactive Protein